Steffen Aulwurm

1.6k total citations
16 papers, 1.3k citations indexed

About

Steffen Aulwurm is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Steffen Aulwurm has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Steffen Aulwurm's work include Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune Cell Function and Interaction (4 papers). Steffen Aulwurm is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune Cell Function and Interaction (4 papers). Steffen Aulwurm collaborates with scholars based in Germany, United States and Switzerland. Steffen Aulwurm's co-authors include Michael Weller, Michael Platten, Ulrike Naumann, Wolfgang Wick, J. Dichgans, Jörg Wischhusen, Kensuke Egashira, Alexandra Kretz, Stefan Isenmann and Ulrich Herrlinger and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Steffen Aulwurm

16 papers receiving 1.3k citations

Peers

Steffen Aulwurm

IMMUN

ONCOL

GENET

Chrystelle Lamagna United States

Kevin Wei United States

Samantha J. Busfield Australia

Tyler Alban United States

Masanori Miyanishi Japan

Mihaela Lorger United Kingdom

K Wright Australia

Piotr Jachimczak Germany

Gregory W. Henkel United States

Alexandre Moulin Switzerland

Chrystelle Lamagna United States

Steffen Aulwurm

605 ×1.0

IMMUN

439 ×0.7

270 ×0.6

ONCOL

131 ×0.5

GENET

167 ×1.4

Citations per year, relative to Steffen Aulwurm Steffen Aulwurm (= 1×) peers Chrystelle Lamagna

Countries citing papers authored by Steffen Aulwurm

Since Specialization

Citations

This map shows the geographic impact of Steffen Aulwurm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Aulwurm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Aulwurm more than expected).

Fields of papers citing papers by Steffen Aulwurm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Aulwurm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Aulwurm. The network helps show where Steffen Aulwurm may publish in the future.

Co-authorship network of co-authors of Steffen Aulwurm

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Aulwurm. A scholar is included among the top collaborators of Steffen Aulwurm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Aulwurm. Steffen Aulwurm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Schlegel, Patrick, Ludger Große‐Hovest, Martin Hofmann, et al.. (2016). Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody. Molecular Therapy. 24(9). 1634–1643. 17 indexed citations

Salih, Helmut R., Martin Hofmann‐Apitius, Ludger Große‐Hovest, et al.. (2013). Elimination Of Minimal Residual Disease (MRD) In AML Patients With a Novel Fc-Optimized FLT3 Antibody (4G8-SDIEM). Blood. 122(21). 1454–1454. 5 indexed citations

Große‐Hovest, Ludger, Patrick Schlegel, Martin Hofmann, et al.. (2013). From Bedside To Bench: Molecular Benchmarking Of An Fc-Optimized CD19 Antibody Used In Treatment Of Relapsed and Refractory Pediatric B-Lineage Acute Lymphoblastic Leukemia. Blood. 122(21). 3905–3905. 1 indexed citations

Hofmann, Martin, Ludger Große‐Hovest, Elwira Pyż, et al.. (2012). Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia. Leukemia. 26(6). 1228–1237. 61 indexed citations

Eisele, Günter, Peter Roth, Kathy Hasenbach, et al.. (2010). APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo. Neuro-Oncology. 13(2). 155–164. 38 indexed citations

Miller, James, Ghazaleh Tabatabai, Steffen Aulwurm, et al.. (2009). Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma. Journal of neurosurgery. 113(2). 280–285. 24 indexed citations

Scheel, Birgit, Steffen Aulwurm, Jochen Probst, et al.. (2006). Therapeutic anti‐tumor immunity triggered by injections of immunostimulating single‐stranded RNA. European Journal of Immunology. 36(10). 2807–2816. 93 indexed citations

Roth, Patrick, Steffen Aulwurm, Dagmar Beier, et al.. (2006). Regeneration and Tolerance Factor: A Novel Mediator of Glioblastoma-Associated Immunosuppression. Cancer Research. 66(7). 3852–3858. 20 indexed citations

Aulwurm, Steffen, Jörg Wischhusen, Manuel A. Friese, Jannie Borst, & Michael Weller. (2005). Immune stimulatory effects of CD70 override CD70‐mediated immune cell apoptosis in rodent glioma models and confer long‐lasting antiglioma immunity in vivo. International Journal of Cancer. 118(7). 1728–1735. 31 indexed citations

10.

Herrlinger, Ulrich, et al.. (2004). MIP-1α Antagonizes the Effect of a GM-CSF-Enhanced Subcutaneous Vaccine in a Mouse Glioma Model. Journal of Neuro-Oncology. 66(1-2). 147–154. 12 indexed citations

11.

Uhl, Martin, Steffen Aulwurm, Jörg Wischhusen, et al.. (2004). SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma CellsIn vitroandIn vivo. Cancer Research. 64(21). 7954–7961. 349 indexed citations

12.

Weigert, Cora, Katrin Brodbeck, Frank C. Brosius, et al.. (2003). Evidence for a Novel TGF-β1−Independent Mechanism of Fibronectin Production in Mesangial Cells Overexpressing Glucose Transporters. Diabetes. 52(2). 527–535. 60 indexed citations

13.

Platten, Michael, Alexandra Kretz, Ulrike Naumann, et al.. (2003). Monocyte chemoattractant protein–1 increases microglial infiltration and aggressiveness of gliomas. Annals of Neurology. 54(3). 388–392. 206 indexed citations

14.

Friese, Manuel A., Michael Platten, Stefan Lutz, et al.. (2003). MICA/NKG2D-mediated immunogene therapy of experimental gliomas.. PubMed. 63(24). 8996–9006. 167 indexed citations

15.

Aulwurm, Steffen, Robert Waltereit, Ulrike Naumann, et al.. (2001). Processing of Immunosuppressive Pro-TGF-β1,2 by Human Glioblastoma Cells Involves Cytoplasmic and Secreted Furin-Like Proteases. The Journal of Immunology. 166(12). 7238–7243. 81 indexed citations

16.

Platten, Michael, Wolfgang Wick, Christine Wild‐Bode, et al.. (2000). Transforming Growth Factors β1 (TGF-β1) and TGF-β2 Promote Glioma Cell Migration via Up-Regulation of αVβ3 Integrin Expression. Biochemical and Biophysical Research Communications. 268(2). 607–611. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact